Encysive Pharmaceuticals (MM) News - ENCY | Aktien NASDAQ

Pfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals

Pfizer Inc (NYSE: PFE) announced today that Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer, has extended the...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION...

Encysive Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A Tender Offer Statement under Section 14(d)(1) or...

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Encysive Pharmaceuticals (MM) (ENCY)

Professionelle Tools für Privatanleger.

ENCY Nachrichten

Pfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Current report filing (8-K)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

ENCY Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Encysive Pharmaceuticals (MM) (ENCY) News

Encysive Pharmaceuticals (MM) (ENCY)

Professionelle Tools für Privatanleger.

ENCY Nachrichten

Pfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)

Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A)

Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)

Encysive Pharmaceuticals Inc - Current report filing (8-K)

Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)

ENCY Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen